Triheptanoin for the treatment of Long-Chain Fatty Acid Disorders (LC-FAOD): Final results of an open-label, long-term extension study

被引：2
|
作者：
Vockley, Jerry [1 ]
Burton, Barbara [2 ]
Berry, Gerard [3 ]
Longo, Nicola [4 ]
Phillips, John [5 ]
Sanchez-Valle, Amarilis [6 ]
Chapman, Kimberly [7 ]
Tanpaiboon, Pranoot [7 ]
Grunewald, Stephanie [8 ,9 ]
Murphy, Elaine [10 ]
Lu, Xiaoxiao [11 ]
Rahman, Syeda [11 ]
Ray, Kathryn [11 ]
Ramirez, Antonio Nino [11 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Ann & Robert H Lurie Childrens Hosp, Chicago, IL USA
[3] Boston Children Hosp, Boston, MA USA
[4] Univ Utah, Salt Lake City, UT 84112 USA
[5] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[6] USF Hlth, Morsani Coll Med, Tampa, FL USA
[7] Childrens Natl Hlth Syst, Washington, DC USA
[8] Great Ormond St Hosp Sick Children, London, England
[9] UCL Inst Child Hlth, NIHR BRC, London, England
[10] Natl Hosp Neurol & Neurosurg, London, England
[11] Ultragenyx Pharmaceut Inc, Novato, CA USA
来源：
GENETICS IN MEDICINE | 2022年 / 24卷 / 03期
关键词：
D O I：
10.1016/j.gim.2022.01.567
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
OP017
引用
收藏
页码：S349 / S349
页数：1
相关论文
共 50 条
  • [1] Triheptanoin for the treatment of long-chain fatty acid oxidation disorders: Final results of an open-label, long-term extension study
    Vockley, Jerry
    Burton, Barbara K. K.
    Berry, Gerard
    Longo, Nicola
    Phillips, John
    Sanchez-Valle, Amarilis
    Chapman, Kimberly A. A.
    Tanpaiboon, Pranoot
    Grunewald, Stephanie
    Murphy, Elaine
    Lu, Xiaoxiao
    Rahman, Syeda
    Ray, Kathryn
    Reineking, Bridget
    Pisani, Laura
    Ramirez, Antonio Nino
    JOURNAL OF INHERITED METABOLIC DISEASE, 2023, 46 (05) : 943 - 955
  • [2] IMPROVEMENTS IN MAJOR CLINICAL EVENTS IN CHILDREN TREATED WITH TRIHEPTANOIN FOR LONG-CHAIN FATTY ACID OXIDATION DISORDERS (LC-FAOD)
    Ray, Kathryn
    Pisani, Laura
    Lu, Xiaoxiao
    Vockley, Jerry
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (04) : 295 - 296
  • [3] Improvement in left ventricular ejection fraction in patients treated with triheptanoin for Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
    Ray, Kathryn
    Vockley, Jerry
    Ramirez, Antonio Nino
    Lu, Xiaoxiao
    Gillingham, Melanie
    GENETICS IN MEDICINE, 2022, 24 (03) : S101 - S101
  • [4] Management and symptoms of people living with long-chain fatty acid oxidation disorders (LC-FAOD) in the United States: Results from LC-FAOD Odyssey Study
    Kruger, E.
    Yang, E.
    Thompson, A.
    Reineking, B.
    MOLECULAR GENETICS AND METABOLISM, 2022, 136 : S15 - S16
  • [5] INTERIM RESULTS FROM AN OPEN-LABEL PHASE 2 STUDY TO ASSESS SAFETY AND CLINICAL EFFECTS OF INVESTIGATIONAL UX007 (TRIHEPTANOIN) IN SUBJECTS WITH LONG-CHAIN FATTY ACID OXIDATION DISORDERS (LC-FAOD)
    Vockley, Jerry
    Burton, Barbara
    Berry, Gerard
    Longo, Nicola
    Phillips, John A.
    Sanchez-Valle, Amarilis
    Tanpaiboon, Pranoot
    Grunwald, Stephanie
    Murphy, Elaine
    Bowden, Alexandra
    Cataldo, Jason
    Marsden, Deborah
    Kakkis, Emil
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (03) : 291 - 291
  • [6] A long-term, prospective, multicenter, in-clinic and online disease monitoring program (DMP) for patients with long-chain fatty acid oxidation disorders (LC-FAOD)
    Ramirez, Antonio Nino
    Polowski, Michelle
    McMahon, Kevin
    Bedrosian, Camille
    Marsden, Deborah
    Rahman, Syeda
    Ray, Kathryn
    Vockley, Jerry
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S20 - S21
  • [7] MAJOR CLINICAL MANIFESTATIONS AND EVENTS AMONG PATIENTS WITH LONG-CHAIN FATTY ACID OXIDATION DISORDERS (LC-FAOD) IN THE UNITED STATES: REAL-WORLD RESULTS FROM LC-FAOD ODYSSEY
    Yang, E.
    Kruger, E.
    Deering, K.
    Stubbe, C.
    Mace, K.
    Tierney, M.
    Cibelli, E.
    Drozd, D.
    Ross, N.
    Herout, P.
    Shillington, A.
    Thomas, N. A.
    Marsden, D.
    Kritzer, A.
    VALUE IN HEALTH, 2022, 25 (07) : S311 - S312
  • [8] SYMPTOMS, TREATMENT EFFECTIVENESS AND QUALITY OF LIFE FOR PATIENTS LIVING WITH LONG-CHAIN FATTY ACID OXIDATION DISORDERS (LC-FAOD) IN THE UNITED STATES: PATIENT AND CAREGIVER REPORTED OUTCOMES FROM LC-FAOD ODYSSEY
    Yang, E.
    Kruger, E.
    Thompson, A.
    Reineking, B.
    VALUE IN HEALTH, 2023, 26 (06) : S354 - S355
  • [9] Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD)
    Vockley, Jerry
    Burton, Barbara
    Berry, Gerard T.
    Longo, Nicola
    Phillips, John
    Sanchez-Valle, Amarilis
    Tanpaiboon, Pranoot
    Grunewald, Stephanie
    Murphy, Elaine
    Bowden, Alexandra
    Chen, Wencong
    Chen, Chao-Yin
    Cataldo, Jason
    Marsden, Deborah
    Kakkis, Emil
    JOURNAL OF INHERITED METABOLIC DISEASE, 2019, 42 (01) : 169 - 177
  • [10] Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders
    Thomas Zöggeler
    Katharina Stock
    Monika Jörg-Streller
    Johannes Spenger
    Vassiliki Konstantopoulou
    Miriam Hufgard-Leitner
    Sabine Scholl-Bürgi
    Daniela Karall
    Orphanet Journal of Rare Diseases, 16
12345